chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Balance disorder, Chills, Communication disorder, Diarrhoea
Clinical narrative: a disconnect/confusion in communicating thoughts to verbal communications or written communications; initial imbalance; flush face; dizzy/unsteady; diarrhea; lethargic; swollen lymph nodes/glands in neck; nausea; headache; body aches; chills; joint pain; fever; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady) and DIARRHOEA (diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion). At the time of the report, COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion) outcome was unknown.            No concomitant medications were provided No treatment medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Flushing, Headache, Lethargy
Clinical narrative: a disconnect/confusion in communicating thoughts to verbal communications or written communications; initial imbalance; flush face; dizzy/unsteady; diarrhea; lethargic; swollen lymph nodes/glands in neck; nausea; headache; body aches; chills; joint pain; fever; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady) and DIARRHOEA (diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion). At the time of the report, COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion) outcome was unknown.            No concomitant medications were provided No treatment medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenitis, Myalgia, Nausea, Pyrexia
Clinical narrative: a disconnect/confusion in communicating thoughts to verbal communications or written communications; initial imbalance; flush face; dizzy/unsteady; diarrhea; lethargic; swollen lymph nodes/glands in neck; nausea; headache; body aches; chills; joint pain; fever; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady) and DIARRHOEA (diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion). At the time of the report, COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion) outcome was unknown.            No concomitant medications were provided No treatment medications were provided
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on different areas of the body - chest and face; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on different areas of the body - chest and face) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash on different areas of the body - chest and face). At the time of the report, RASH (rash on different areas of the body - chest and face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment medications were provided
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Malaise, Pain, Paraesthesia
Clinical narrative: radiating pain; numbness; tingling; fatigue; malaise; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (radiating pain), HYPOAESTHESIA (numbness), PARAESTHESIA (tingling), FATIGUE (fatigue) and MALAISE (malaise) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Respiratory infection (Respiratory issues like (asthma,lung damage, frequent  sinus conditions)) and Lung damage.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2. On an unknown date, the patient experienced PAIN (radiating pain), HYPOAESTHESIA (numbness), PARAESTHESIA (tingling), FATIGUE (fatigue) and MALAISE (malaise). The patient was treated with ACETAMINOPHEN (oral) ongoing since an unknown date at a dose of 1000 mg and METHYLPREDNISOLONE (METHYL PRED) (oral) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN (radiating pain), HYPOAESTHESIA (numbness), PARAESTHESIA (tingling), FATIGUE (fatigue) and MALAISE (malaise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Acetaminophen-1000mg and methyl [prednisolone drugs are used as treatment
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Suspected counterfeit product
Clinical narrative: Anxiety; lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety) and SUSPECTED COUNTERFEIT PRODUCT (lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032K20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced SUSPECTED COUNTERFEIT PRODUCT (lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker). On an unknown date, the patient experienced ANXIETY (Anxiety). On 27-Jan-2021, SUSPECTED COUNTERFEIT PRODUCT (lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker) had resolved. At the time of the report, ANXIETY (Anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Inappropraite age at vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropraite age at vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropraite age at vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropraite age at vaccine) had resolved.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea
Clinical narrative: dizziness; nausea; fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (dizziness), NAUSEA (nausea) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 28-Mar-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, DIZZINESS (dizziness), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received Moderna vaccine for second dose instead of Pfizer vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Apr-2021 and was forwarded to Moderna on 20-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received Moderna vaccine for second dose instead of Pfizer vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 09-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received Moderna vaccine for second dose instead of Pfizer vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received Moderna vaccine for second dose instead of Pfizer vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Injected limb mobility decreased, Nausea, Peripheral swelling
Clinical narrative: swollen shoulder/ left arm swollen; Arm was tender with red patch; Arm was tender; nauseous; dizzy; Left sholder became swollen and she can't lift it; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen shoulder/ left arm swollen), NAUSEA (nauseous), DIZZINESS (dizzy), INJECTED LIMB MOBILITY DECREASED (Left sholder became swollen and she can't lift it) and ERYTHEMA (Arm was tender with red patch) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001J20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 02-Feb-2021, the patient experienced NAUSEA (nauseous), DIZZINESS (dizzy) and INJECTED LIMB MOBILITY DECREASED (Left sholder became swollen and she can't lift it). On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen shoulder/ left arm swollen), ERYTHEMA (Arm was tender with red patch) and TENDERNESS (Arm was tender). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Swollen arm, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (swollen shoulder/ left arm swollen) was resolving, NAUSEA (nauseous), INJECTED LIMB MOBILITY DECREASED (Left sholder became swollen and she can't lift it), ERYTHEMA (Arm was tender with red patch) and TENDERNESS (Arm was tender) outcome was unknown and DIZZINESS (dizzy) had resolved.            No concomitant medication was taken.   This case was linked to US-MODERNATX, INC.-MOD-2021-016520 (E2B Linked Report). This case was linked to MOD-2021-016520 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-APR-2021. The patient age changes to 84. In initial report date for second dose was mentioned as 02-Feb-2021 and in follow-up it is mentioned as 04-Feb-2021. The patient took Advil as treatment medication. The patient reported that after taking Advil for her swollen arm, it worked. The patient also reported a new event that her arm was tender.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016520:Same patient, 2nd dose
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: swollen shoulder/ left arm swollen; Arm was tender with red patch; Arm was tender; nauseous; dizzy; Left sholder became swollen and she can't lift it; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen shoulder/ left arm swollen), NAUSEA (nauseous), DIZZINESS (dizzy), INJECTED LIMB MOBILITY DECREASED (Left sholder became swollen and she can't lift it) and ERYTHEMA (Arm was tender with red patch) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001J20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 02-Feb-2021, the patient experienced NAUSEA (nauseous), DIZZINESS (dizzy) and INJECTED LIMB MOBILITY DECREASED (Left sholder became swollen and she can't lift it). On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen shoulder/ left arm swollen), ERYTHEMA (Arm was tender with red patch) and TENDERNESS (Arm was tender). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Swollen arm, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (swollen shoulder/ left arm swollen) was resolving, NAUSEA (nauseous), INJECTED LIMB MOBILITY DECREASED (Left sholder became swollen and she can't lift it), ERYTHEMA (Arm was tender with red patch) and TENDERNESS (Arm was tender) outcome was unknown and DIZZINESS (dizzy) had resolved.            No concomitant medication was taken.   This case was linked to US-MODERNATX, INC.-MOD-2021-016520 (E2B Linked Report). This case was linked to MOD-2021-016520 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-APR-2021. The patient age changes to 84. In initial report date for second dose was mentioned as 02-Feb-2021 and in follow-up it is mentioned as 04-Feb-2021. The patient took Advil as treatment medication. The patient reported that after taking Advil for her swollen arm, it worked. The patient also reported a new event that her arm was tender.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016520:Same patient, 2nd dose
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, Paraesthesia
Clinical narrative: mild fever; chills; fatigue; nausea; Dizziness; tingling of extremities; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), PARAESTHESIA (tingling of extremities), PYREXIA (mild fever), CHILLS (chills) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Mood disorder since 1989. Concomitant products included VITAMIN D [VITAMIN D NOS], ACETYLSALICYLIC ACID (BABY ASPIRIN), SERTRALINE and LAMOTRIGINE for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (Dizziness), PARAESTHESIA (tingling of extremities) and NAUSEA (nausea). On an unknown date, the patient experienced PYREXIA (mild fever), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of UNK, qh. On 19-Mar-2021, DIZZINESS (Dizziness) and NAUSEA (nausea) had resolved. On 19-May-2021, PARAESTHESIA (tingling of extremities) had resolved. At the time of the report, PYREXIA (mild fever), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Added new event tingling of extremities, added start date of events nausea and dizziness, added patient information, added batch number, a, dded treatment concomitant and treatment information Added other relevant history . Updated outcome of events of nausea, dizziness.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: mild fever; chills; fatigue; nausea; Dizziness; tingling of extremities; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), PARAESTHESIA (tingling of extremities), PYREXIA (mild fever), CHILLS (chills) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Mood disorder since 1989. Concomitant products included VITAMIN D [VITAMIN D NOS], ACETYLSALICYLIC ACID (BABY ASPIRIN), SERTRALINE and LAMOTRIGINE for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (Dizziness), PARAESTHESIA (tingling of extremities) and NAUSEA (nausea). On an unknown date, the patient experienced PYREXIA (mild fever), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of UNK, qh. On 19-Mar-2021, DIZZINESS (Dizziness) and NAUSEA (nausea) had resolved. On 19-May-2021, PARAESTHESIA (tingling of extremities) had resolved. At the time of the report, PYREXIA (mild fever), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Added new event tingling of extremities, added start date of events nausea and dizziness, added patient information, added batch number, a, dded treatment concomitant and treatment information Added other relevant history . Updated outcome of events of nausea, dizziness.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Peripheral swelling, Pyrexia, Rash
Clinical narrative: arm swelled up; arm broke out in rash; fever; belly cramping; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (belly cramping), PERIPHERAL SWELLING (arm swelled up), RASH (arm broke out in rash) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced ABDOMINAL PAIN (belly cramping). On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelled up), RASH (arm broke out in rash) and PYREXIA (fever). At the time of the report, ABDOMINAL PAIN (belly cramping) outcome was unknown, PERIPHERAL SWELLING (arm swelled up) and RASH (arm broke out in rash) had not resolved and PYREXIA (fever) had resolved.            She also had a fever and felt bad for 24 hours Patient used Tylenol to treat fever.
Sex: U
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ocrelizumab (Ocrevus) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Additional information document received on 28-APR-2021 Contains updated concomitant medications.
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 y.o was given the Moderna shot; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 y.o was given the Moderna shot) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021 at 8:20 AM, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 y.o was given the Moderna shot). On 19-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 y.o was given the Moderna shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: pretty strong reaction; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (pretty strong reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (pretty strong reaction). At the time of the report, HYPERSENSITIVITY (pretty strong reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and No Treatment Medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: felt crappy; This spontaneous case was reported by a physician and describes the occurrence of FEELING ABNORMAL (felt crappy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt crappy). At the time of the report, FEELING ABNORMAL (felt crappy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: body pain; fever; headache; fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body pain), PYREXIA (fever), HEADACHE (headache) and FATIGUE (fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MYALGIA (body pain), PYREXIA (fever), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, MYALGIA (body pain), PYREXIA (fever), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Folllow-up information received on 26-JUL-2021 contains non significant information.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment and concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: blood comes out immediately after he get the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (blood comes out immediately after he get the shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (blood comes out immediately after he get the shot). At the time of the report, VACCINATION SITE HAEMORRHAGE (blood comes out immediately after he get the shot) outcome was unknown.            No concomitant medication were reported.  No treatment medication were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (slight headache) and MYALGIA (body soreness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (slight headache) and MYALGIA (body soreness). At the time of the report, HEADACHE (slight headache) and MYALGIA (body soreness) outcome was unknown.            No concomitant medications were provided. No treatment drugs were reported.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Rash erythematous, Vaccination site pruritus
Clinical narrative: red rash--at least a hand width wide; fatigue; injection site itching "driving me crazy"; joint pain...it was bad; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash--at least a hand width wide), FATIGUE (fatigue), ARTHRALGIA (joint pain...it was bad) and VACCINATION SITE PRURITUS (injection site itching "driving me crazy") in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced ARTHRALGIA (joint pain...it was bad). On 19-Apr-2021, the patient experienced RASH ERYTHEMATOUS (red rash--at least a hand width wide), FATIGUE (fatigue) and VACCINATION SITE PRURITUS (injection site itching "driving me crazy"). On 19-Apr-2021, ARTHRALGIA (joint pain..it was bad) had resolved. At the time of the report, RASH ERYTHEMATOUS (red rash--at least a hand width wide), FATIGUE (fatigue) and VACCINATION SITE PRURITUS (injection site itching "driving me crazy") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment taken included A&D Diaper Rash Ointment, and also baking soda -- neither helped with the itching.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Fever; Diagnosed with covid-19; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and SARS-COV-2 TEST POSITIVE (Diagnosed with covid-19) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PYREXIA (Fever) and SARS-COV-2 TEST POSITIVE (Diagnosed with covid-19). At the time of the report, PYREXIA (Fever) and SARS-COV-2 TEST POSITIVE (Diagnosed with covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: vaccine inadvertently given to a 16 year old patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine inadvertently given to a 16 year old patient) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 21-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine inadvertently given to a 16 year old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine inadvertently given to a 16 year old patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   Reporter did not allow further contact
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Vaccination site erythema; Vaccination site swelling; Vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included LOSARTAN for Blood pressure high, ESCITALOPRAM OXALATE (LEXAPRO), ALPRAZOLAM (XANAX) and TOPIRAMATE for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE PRURITUS (Vaccination site pruritus). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE PRURITUS (Vaccination site pruritus) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details include Advil, Benadryl cream and Ice.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Added additional reporter detailsAdded concomitant medication (LOSARTAN)
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Myalgia, Pain, Pyrexia
Clinical narrative: About 12 hours later after 2nd dose, she started with really bad ringing in her ears; She felt like she was confused; Light headed; She had fever; aches; pain; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (About 12 hours later after 2nd dose, she started with really bad ringing in her ears), CONFUSIONAL STATE (She felt like she was confused), DIZZINESS (Light headed), PYREXIA (She had fever) and MYALGIA (aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03A21A and 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 24-Mar-2021, the patient experienced TINNITUS (About 12 hours later after 2nd dose, she started with really bad ringing in her ears), CONFUSIONAL STATE (She felt like she was confused), DIZZINESS (Light headed), PYREXIA (She had fever), MYALGIA (aches) and PAIN (pain). At the time of the report, TINNITUS (About 12 hours later after 2nd dose, she started with really bad ringing in her ears), CONFUSIONAL STATE (She felt like she was confused), DIZZINESS (Light headed), PYREXIA (She had fever), MYALGIA (aches) and PAIN (pain) outcome was unknown.            patient was treated with Tylenol for fever and aches.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: About 12 hours later after 2nd dose, she started with really bad ringing in her ears; She felt like she was confused; Light headed; She had fever; aches; pain; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (About 12 hours later after 2nd dose, she started with really bad ringing in her ears), CONFUSIONAL STATE (She felt like she was confused), DIZZINESS (Light headed), PYREXIA (She had fever) and MYALGIA (aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03A21A and 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 24-Mar-2021, the patient experienced TINNITUS (About 12 hours later after 2nd dose, she started with really bad ringing in her ears), CONFUSIONAL STATE (She felt like she was confused), DIZZINESS (Light headed), PYREXIA (She had fever), MYALGIA (aches) and PAIN (pain). At the time of the report, TINNITUS (About 12 hours later after 2nd dose, she started with really bad ringing in her ears), CONFUSIONAL STATE (She felt like she was confused), DIZZINESS (Light headed), PYREXIA (She had fever), MYALGIA (aches) and PAIN (pain) outcome was unknown.            patient was treated with Tylenol for fever and aches.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Blood pressure abnormal, Blood pressure increased, Chills, Headache
Clinical narrative: blood pressure has not been normal since the vaccine , it is either too high or too low; headache; high blood pressure of 200/100; high fever around 102-103; chills; developed knots on both side of legs; stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of MASS (developed knots on both side of legs), ABDOMINAL PAIN UPPER (stomach pain), BLOOD PRESSURE INCREASED (high blood pressure of 200/100), BLOOD PRESSURE ABNORMAL (blood pressure has not been normal since the vaccine , it is either too high or too low) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced MASS (developed knots on both side of legs) and ABDOMINAL PAIN UPPER (stomach pain). On 26-Mar-2021, the patient experienced CHILLS (chills) and PYREXIA (high fever around 102-103). On 27-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (high blood pressure of 200/100) and HEADACHE (headache). On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (blood pressure has not been normal since the vaccine , it is either too high or too low). On 25-Mar-2021, MASS (developed knots on both side of legs) and ABDOMINAL PAIN UPPER (stomach pain) had resolved. On 26-Mar-2021, CHILLS (chills) and PYREXIA (high fever around 102-103) had resolved. On 08-Apr-2021, BLOOD PRESSURE INCREASED (high blood pressure of 200/100) had resolved. At the time of the report, BLOOD PRESSURE ABNORMAL (blood pressure has not been normal since the vaccine , it is either too high or too low) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information included extra BP pill Anatril  20mg,Tylenol  for fever and headache. Upon internal review on 4-Aug-21, the age was corrected to 62 years.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pyrexia
Clinical narrative: blood pressure has not been normal since the vaccine , it is either too high or too low; headache; high blood pressure of 200/100; high fever around 102-103; chills; developed knots on both side of legs; stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of MASS (developed knots on both side of legs), ABDOMINAL PAIN UPPER (stomach pain), BLOOD PRESSURE INCREASED (high blood pressure of 200/100), BLOOD PRESSURE ABNORMAL (blood pressure has not been normal since the vaccine , it is either too high or too low) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced MASS (developed knots on both side of legs) and ABDOMINAL PAIN UPPER (stomach pain). On 26-Mar-2021, the patient experienced CHILLS (chills) and PYREXIA (high fever around 102-103). On 27-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (high blood pressure of 200/100) and HEADACHE (headache). On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (blood pressure has not been normal since the vaccine , it is either too high or too low). On 25-Mar-2021, MASS (developed knots on both side of legs) and ABDOMINAL PAIN UPPER (stomach pain) had resolved. On 26-Mar-2021, CHILLS (chills) and PYREXIA (high fever around 102-103) had resolved. On 08-Apr-2021, BLOOD PRESSURE INCREASED (high blood pressure of 200/100) had resolved. At the time of the report, BLOOD PRESSURE ABNORMAL (blood pressure has not been normal since the vaccine , it is either too high or too low) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information included extra BP pill Anatril  20mg,Tylenol  for fever and headache. Upon internal review on 4-Aug-21, the age was corrected to 62 years.